{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:58:17Z","timestamp":1781233097397,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10517-026-06684-z","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:06:59Z","timestamp":1780420019000},"page":"603-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidepressant Activity of 11-Dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole Derivative DAB-21 in a Model of Chronic Unpredictable Mild Stress"],"prefix":"10.1007","volume":"180","author":[{"given":"M. O.","family":"Maltseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. V.","family":"Maltsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Miroshnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. N.","family":"Divaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Morkovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Spasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"6684_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-981-32-9705-0_14","volume":"1191","author":"KW Choi","year":"2020","unstructured":"Choi KW, Kim YK, Jeon HJ. Comorbid anxiety and depression: Clinical and conceptual consideration and transdiagnostic treatment. Adv Exp Med Biol. 2020;1191:219-35. https:\/\/doi.org\/10.1007\/978-981-32-9705-0_14","journal-title":"Adv Exp Med Biol."},{"key":"6684_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jad.2016.08.006","volume":"216","author":"K Kircanski","year":"2017","unstructured":"Kircanski K, LeMoult J, Ordaz S, et al. Investigating the nature of co-occurring depression and anxiety: Comparing diagnostic and dimensional research approaches. J Affect Disord. 2017;216:123-35. https:\/\/doi.org\/10.1016\/j.jad.2016.08.006","journal-title":"J Affect Disord."},{"key":"6684_CR3","first-page":"24","volume":"1","author":"AS Taran","year":"2017","unstructured":"Taran AS, Maltsev DV, Yakovlev DS, et al. A study of anxiolytic activity of new diazepinobenzimidazoles in the elevated plus maze test. Volgogradskij Nau\u010dno-Medicinskij \u017durnal. 2017;(1):24-6. (In Russ.).","journal-title":"Volgogradskij Nau\u010dno-Medicinskij \u017durnal."},{"key":"6684_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105792","volume":"161","author":"DV Maltsev","year":"2021","unstructured":"Maltsev DV, Spasov AA, Yakovlev DS, et al. Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole. Eur J Pharm Sci. 2021;161:105792. https:\/\/doi.org\/10.1016\/j.ejps.2021.105792","journal-title":"Eur J Pharm Sci."},{"issue":"1","key":"6684_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10517-023-05811-4","volume":"175","author":"IG Kapitsa","year":"2023","unstructured":"Kapitsa IG, Alymov AA, Savinkova EV, Voronina TA, Seredenin SB. Experimental study of antidepressant properties of Afobazole. Bull Exp Biol Med. 2023;175(1):59-62. https:\/\/doi.org\/10.1007\/s10517-023-05811-4","journal-title":"Bull Exp Biol Med."},{"key":"6684_CR6","doi-asserted-by":"publisher","unstructured":"Spasov AA, Mal\u2019tsev DV, Miroshnikov MV, et al. The antidepressant activity of diazepinobenbenzimidazole derivative DAB-19 and its potential mechanisms of action. Experimental and Clinical Pharmacology. 2020;83(4):31-6. (In Russ.). https:\/\/doi.org\/10.30906\/0869-2092-2020-83-4-31-36","DOI":"10.30906\/0869-2092-2020-83-4-31-36"},{"key":"6684_CR7","doi-asserted-by":"publisher","unstructured":"Kapitsa IG, Alymov AA, Savinkova EV, et al. Effect of afobazole and fluoxetine on depressive-like behavior of male and female BALB\/C mice with model autism spectrum disorders. Experimental and Clinical Pharmacology. 2022;85(7):3-7. (In Russ.). https:\/\/doi.org\/10.30906\/0869-2092-2022-85-7-3-7","DOI":"10.30906\/0869-2092-2022-85-7-3-7"},{"issue":"2","key":"6684_CR8","first-page":"5","volume":"15","author":"PD Shabanov","year":"2016","unstructured":"Shabanov PD, Morozov AI, Lebedev AA, et al. Experimental study of a new anxiolytic tranquiridine. Vestnik Smolenskoj Gosudarstvennoj Medicinskoj Akademii. 2016;15(2):5-14. (In Russ.).","journal-title":"Vestnik Smolenskoj Gosudarstvennoj Medicinskoj Akademii."},{"issue":"2","key":"6684_CR9","first-page":"23","volume":"84","author":"MG Balasanyan","year":"2021","unstructured":"Balasanyan MG, Kanayan AS, Topchyan HV, et al. Neuroprotective activity of afobazole in ischemized brain. Experimental and Clinical Pharmacology. 2021;84(2):23-7. (In Russ.).","journal-title":"Experimental and Clinical Pharmacology."},{"key":"6684_CR10","doi-asserted-by":"publisher","unstructured":"Maltsev DV, Spasov AA, Miroshnikov MV, et al. Analysis of interaction of the diazepino[1,2-a]benzimidazole derivative compound DAB-21 with the main neuromediator systems ligands. Vestnik Volgogradskogo Gosudarstvennogo Medicinskogo Universiteta. 2021;(1):131-6. (In Russ.). https:\/\/doi.org\/10.19163\/1994-9480-2021-1(77)-131-136","DOI":"10.19163\/1994-9480-2021-1(77)-131-136"},{"issue":"9","key":"6684_CR11","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/cns.14207","volume":"29","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang Y, Wang J, et al. Anti-neuroinflammation effects of transcutaneous auricular vagus nerve stimulation against depression-like behaviors via hypothalamic \u03b17nAchR\/JAK2\/STAT3\/NF-\u03baB pathway in rats exposed to chronic unpredictable mild stress. CNS Neurosci Ther. 2023;29(9):2634-44. https:\/\/doi.org\/10.1111\/cns.14207","journal-title":"CNS Neurosci Ther."},{"key":"6684_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.biopha.2018.10.073","volume":"111","author":"H Ueno","year":"2019","unstructured":"Ueno H, Shimada A, Suemitsu S, et al. Anti-depressive-like effect of 2-phenylethanol inhalation in mice. Biomed Pharmacother. 2019;111:1499-506. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.073","journal-title":"Biomed Pharmacother."},{"key":"6684_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173433","volume":"218","author":"CM De Arruda","year":"2022","unstructured":"De Arruda CM, Doneda DL, de Oliveira VV, et al. Involvement of kynurenine pathway and N-methyl-d-aspartate receptors in the antidepressant-like effect of vilazodone in the tail suspension test in mice. Pharmacol Biochem Behav. 2022;218:173433. https:\/\/doi.org\/10.1016\/j.pbb.2022.173433","journal-title":"Pharmacol Biochem Behav."},{"key":"6684_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.biopha.2018.04.077","volume":"103","author":"DM Da Silva","year":"2018","unstructured":"Da Silva DM, Sanz G, Vaz BG, et al. Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl)methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system. Biomed Pharmacother. 2018;103:546-52. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.077","journal-title":"Biomed Pharmacother."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06684-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:49:51Z","timestamp":1781232591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06684-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6684"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06684-z","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}